127 related articles for article (PubMed ID: 7133029)
21. The effects of pre-incubation period and norharman on the mutagenic potency of 4-dimethylaminoazobenzene and 3'-methyl-4-dimethylaminoazobenzene in S. typhimurium.
Lefevre PA; Ashby J
Carcinogenesis; 1981; 2(9):927-31. PubMed ID: 6794927
[TBL] [Abstract][Full Text] [Related]
22. Human exposure to mutagenic/carcinogenic heterocyclic amines and comutagenic beta-carbolines.
Wakabayashi K; Totsuka Y; Fukutome K; Oguri A; Ushiyama H; Sugimura T
Mutat Res; 1997 May; 376(1-2):253-9. PubMed ID: 9202762
[TBL] [Abstract][Full Text] [Related]
23. Carcinogenic, Mutagenic, and Comutagenic Aromatic Amines in Human Foods.
Sugimura T; Nagao M
Natl Cancer Inst Monogr; 1981 Dec; (58):27-33. PubMed ID: 7341982
[TBL] [Abstract][Full Text] [Related]
24. Effect of cigarette-smoke condensate and norharman on the induction of SCEs by direct and indirect mutagens in CHO cells.
Rutten AA; Wilmer JW
Mutat Res; 1986 Oct; 172(1):61-7. PubMed ID: 3762569
[TBL] [Abstract][Full Text] [Related]
25. Genotoxic effects of structurally related beta-carboline alkaloids.
Picada JN; da Silva KV; Erdtmann B; Henriques AT; Henriques JA
Mutat Res; 1997 Oct; 379(2):135-49. PubMed ID: 9357543
[TBL] [Abstract][Full Text] [Related]
26. Marked differences between mutagenicity in Salmonella and tumour-initiating activities of dibenzo[a,e]fluoranthene proximate metabolites; initiation inhibiting activity of norharman.
Zajdela F; Perin-Roussel O; Saguem S
Carcinogenesis; 1987 Mar; 8(3):461-4. PubMed ID: 3545527
[TBL] [Abstract][Full Text] [Related]
27. Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gpt delta transgenic mouse.
Masumura K; Totsuka Y; Wakabayashi K; Nohmi T
Carcinogenesis; 2003 Dec; 24(12):1985-93. PubMed ID: 12970073
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the in vitro metabolisms and mutagenicities of dibenzo[a,c]anthracene, dibenzo[a,h]anthracene and dibenzo[a,j]anthracene: influence of norharman.
Lecoq S; Perin F; Plessis MJ; Strapelias H; Duquesne M
Carcinogenesis; 1989 Mar; 10(3):461-9. PubMed ID: 2924394
[TBL] [Abstract][Full Text] [Related]
29. The effects of S9 mix from rat oesophagus, salivary gland, and liver on the mutagenicity of the rat oesophageal carcinogen N-nitroso-N-methylaniline in the Salmonella typhimurium assay.
Anderson D; Blowers SD; Craddock VM
Mutat Res; 1985; 142(1-2):13-8. PubMed ID: 3883137
[TBL] [Abstract][Full Text] [Related]
30. The effect of norharman on the metabolism of benzo[alpha]pyrene by rat-liver microsomes in vitro in relation to its enhancement of the mutagenicity of benzo[alpha]pyrene.
Fujino T; Fujiki H; Nagao M; Yahagi T; Seino Y; Sugimura T
Mutat Res; 1978 Nov; 58(2-3):151-8. PubMed ID: 370567
[TBL] [Abstract][Full Text] [Related]
31. Mutagenicity of nitro derivatives produced by exposure of dibenzofuran to nitrogen oxides.
Watanabe T; Hirayama T
Mutat Res; 1992 Sep; 283(1):35-43. PubMed ID: 1380661
[TBL] [Abstract][Full Text] [Related]
32. SCE induction in human lymphocytes by combined treatment with aniline and norharman.
Takehisa S; Kanaya N
Mutat Res; 1982 Apr; 101(2):165-72. PubMed ID: 7099184
[TBL] [Abstract][Full Text] [Related]
33. Comutagenesis-IV in vitro metabolism of the comutagen 2-amino-3-methylpyridine: species differences and metabolic interaction with norharman.
Altuntas TG; Gorrod JW
Anticancer Res; 1997; 17(6D):4479-82. PubMed ID: 9494554
[TBL] [Abstract][Full Text] [Related]
34. Possibility of the involvement of 9H-pyrido[3,4-b]indole (norharman) in carcinogenesis via inhibition of cytochrome P450-related activities and intercalation to DNA.
Nii H
Mutat Res; 2003 Nov; 541(1-2):123-36. PubMed ID: 14568301
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo formation of aminophenylnorharman from norharman and aniline.
Totsuka Y; Kataoka H; Takamura-Enya T; Sugimura T; Wakabayashi K
Mutat Res; 2002 Sep; 506-507():49-54. PubMed ID: 12351144
[TBL] [Abstract][Full Text] [Related]
36. Mutagenic activity of norharman and harman in Chinese hamster lung cells in assays with diphtheria toxin resistance as a marker.
Nakayasu M; Nakasato F; Sakamoto H; Terada M; Sugimura T
Cancer Lett; 1983 Jan; 17(3):249-55. PubMed ID: 6831382
[No Abstract] [Full Text] [Related]
37. Mutagens formed from beta-carbolines with aromatic amines.
Totsuka Y; Takamura-Enya T; Nishigaki R; Sugimura T; Wakabayashi K
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Mar; 802(1):135-41. PubMed ID: 15036005
[TBL] [Abstract][Full Text] [Related]
38. Induction of sister chromatid exchanges and chromosome aberrations in cultured mammalian cells treated with aminophenylnorharman formed by norharman with aniline.
Ohe T; Takata T; Maeda Y; Totsuka Y; Hada N; Matsuoka A; Tanaka N; Wakabayashi K
Mutat Res; 2002 Mar; 515(1-2):181-8. PubMed ID: 11909766
[TBL] [Abstract][Full Text] [Related]
39. Differences in effects of norharman with various classes of chemical mutagens and amounts of S-9.
Nagao M; Yahagi T; Sugimura T
Biochem Biophys Res Commun; 1978 Jul; 83(2):373-8. PubMed ID: 358980
[No Abstract] [Full Text] [Related]
40. Mutagenicity of carbon tetrachloride and chloroform in Salmonella typhimurium TA98, TA100, TA1535, and TA1537, and Escherichia coli WP2uvrA/pKM101 and WP2/pKM101, using a gas exposure method.
Araki A; Kamigaito N; Sasaki T; Matsushima T
Environ Mol Mutagen; 2004; 43(2):128-33. PubMed ID: 14991753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
